cetuximab,afatinib,pembrolizumab,adagrasib
eli lilly,merck,boehringer ingelheim,mirati
['krystal-1', 'ovarian', 'adagrasib']
krystal-1 data: adagrasib promising activity in kras g12c-mutated ovarian and endometrial cancers. needs tumor testing. no one left behind. #asco23 #ovariancancer #uterinecancer 
Med Oncologist, GYN Women’s Cancer, Search for answers, hopes, right pathways, #YaleCancer, #YaleMedicine, #SmilowCancer